Nov 28 2024 16 mins
Sigal Kalmanson is the CEO and founder of Starget Pharma, an Israeli early-stage clinical company developing a new class of Smart Targeted Radioligands for precision oncology of hard-to-heal cancers.
Avraham sat down with Sigal in the offices of Starget Pharma to discuss why Sigal started Starget, the role of IP in their business, how they got funded, how Sigal became the CEO, tips for startup founders and much more.
Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup.
Also available at https://soundcloud.com/jmbdavis/jumpspeed. Listen to all of the episodes at https://jmbdavis.com/podcast.
Avraham sat down with Sigal in the offices of Starget Pharma to discuss why Sigal started Starget, the role of IP in their business, how they got funded, how Sigal became the CEO, tips for startup founders and much more.
Do you have a great innovation? We'd love to hear from you. Contact us by going to https://jmbdavis.com/startup/contact. Learn more at https://jmbdavis.com and https://jmbdavis.com/startup.
Also available at https://soundcloud.com/jmbdavis/jumpspeed. Listen to all of the episodes at https://jmbdavis.com/podcast.